A melanocortin-4 receptor agonist did not induce significant decreases in BMI for patients with four rare genetic forms of ...
Oestrogen-induced DNA damage drives genomic instability in BRCA1 mutation cells, with dietary compounds showing protective potential.
Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder a person can inherit from a parent. It can cause a person to develop dangerously high cholesterol levels. HeFH affects how a ...
Rhythm Pharmaceuticals (NASDAQ:RYTM) reported Phase 3 top-line results from its EMANATE trial evaluating setmelanotide in ...
Four substudies did not meet pre-specified primary endpoints -- -- Post hoc analyses show setmelanotide achieved ...
Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease
Heterozygous familial hypercholesterolemia (HeFH) is a monogenic disorder that affects about 1 in 500 people, with a higher prevalence in certain subpopulations such as people of Quebecois, Christian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results